Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by mstrmnd

T.ATE

New CEO

New look much needed, at this point, Dan is invisible, and anyone is better

December 4, 2021

T.ATE

New CEO

Coming soon

December 3, 2021

T.ATE

RE:RE:RE:RE:RE:RE:Antibe Partnership to Accelerate Drug Pipeline

They are looking to get at least $1B for Otenaproxesul.  This is the...

November 3, 2021

T.ATE

RE:RE:RE:RE:Antibe Partnership to Accelerate Drug Pipeline

They need to have clarity that chronic indications are feasible but do not...

November 3, 2021

T.ATE

RE:RE:Antibe Partnership to Accelerate Drug Pipeline

If you have an IND/DIN for oral treatment of acute pain, it's natural...

November 3, 2021

T.ATE

Antibe Partnership to Accelerate Drug Pipeline

Based on quality of data from existing studies, I would not be surprised if...

November 2, 2021

T.ATE

$1B for Otenaproxesul (ATB-346)

Will they be able to sell Otenaproxesul to Big Pharma for $1B within 36...

October 22, 2021

T.ATE

Keep selling, I'm buying

ATE.TO Market Cap: $45M Cash: $60M Assets (including unified IP):  1...

October 22, 2021

T.ATE

Impact of Timeline Acceleration

So why is the SP sitting here if time to market is shorter? There's no...

October 22, 2021

T.ATE

RE:RE:RE:RE:How LTE suddenly became a cause of failure

Misinformation spreading so let me out this right away.  ATB-429 parent...

October 21, 2021

T.ATE

RE:RE:Time to Market for H2S Pipeline

This is what the company has reported in AGM and recent release.  There&...

October 17, 2021

T.ATE

RE:RE:RE:RE:RE:RE:RE:RE:RE:Time to Market for H2S Pipeline

Fair.  75 mg (3 tabs) PO daily x 14 days then 25 mg PO daily x 90 days....

October 16, 2021

T.ATE

RE:RE:RE:RE:RE:RE:RE:Time to Market for H2S Pipeline

Yes, completely agree.  This was briefly discussed at the AGM as well by...

October 16, 2021

T.ATE

RE:RE:RE:RE:RE:Time to Market for H2S Pipeline

My take is it's on par with other NSAIDS.  In fact from an API...

October 16, 2021

T.ATE

RE:RE:RE:RE:RE:Time to Market for H2S Pipeline

You are wrong.  There's no need to guess.  Look at the...

October 16, 2021

T.ATE

Next Press Release to Watch Out For

It was confirmed at the AGM that preliminary data on COVID-19 has been...

October 16, 2021

T.ATE

RE:RE:RE:Time to Market for H2S Pipeline

H2S is not toxic, review the 2a and 2b datasets.  5/42 people with LTE...

October 16, 2021

T.ATE

RE:Time to Market for H2S Pipeline

4 drugs: 1. Otenaproxesul (ATB-346): Primary Indication: Post-Operative...

October 16, 2021

T.ATE

Time to Market for H2S Pipeline

That's all that matters. P2b/3a for OA to prove safety and efficacy for...

October 14, 2021

T.ATE

What should the SP be?

Given $67M on hand and non-dilutive delay, what should the SP actually be...

August 20, 2021

1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next

Featured Company

Gemina Laboratories Ltd.

Gemina Laboratories Ltd. C.GLAB

Gemina Laboratories Ltd. is a Canada-based biosensor and diagnostic company with a transformative, patented, proprietary ... view more »